IndraLab

Statements

Disopyramide inhibits mutated KCNH2. 3 / 3
| 3
reach
"In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome : a pilot study."
29697308
reach
"In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome : a pilot study."
17711440
reach
"MCPATE MJ, DUNCAN RS, WITCHEL HJ, HANCOX JC : Disopyramide is an effective inhibitor of mutant HERG K (+) channels involved in variant 1 short QT syndrome."
17298291